Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

Shenzhen Stock Exchange 002675.SZ

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Market Capitalization on January 27, 2025: USD 1.44 B

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. Market Capitalization is USD 1.44 B on January 27, 2025, a -16.46% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.

Yantai Dongcheng Pharmaceutical Group Co.,Ltd. 52-week high Market Capitalization is USD 1.85 B on March 20, 2024, which is 28.30% above the current Market Capitalization.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. 52-week low Market Capitalization is USD 1.32 B on July 04, 2024, which is -8.32% below the current Market Capitalization.
Yantai Dongcheng Pharmaceutical Group Co.,Ltd. average Market Capitalization for the last 52 weeks is USD 1.50 B.

Key data

Date	Market Capitalization	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)

Shenzhen Stock Exchange: 002675.SZ

Yantai Dongcheng Pharmaceutical Group Co.,Ltd.

CEO	Mr. Zhi Gang Luo
IPO Date	May 25, 2012
Location	China
Headquarters	No.7 ChangBaiShan Road
Employees	2,333
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Yantai Dongcheng Pharmaceutical Group Co.,Ltd., together with its subsidiaries, engages in the manufacture and sale of biochemical API, chemical medicines, proprietary Chinese medicines, and nuclide drugs products in China. It offers heparin, chondroitin sulphate, and glucosamine series products, as well as collagen, hyaluronic acid, and cytochrome C for use in the therapeutic areas of cardiovascular, oncology, urology, orthopedics, and other therapeutic areas. The company also exports its products to approximately 40 countries and regions, including the Europe, America, Asia Pacific, and internationally. Yantai Dongcheng Pharmaceutical Group Co.,Ltd. was founded in 1998 and is based in Yantai, China.

Key trends

Past 5 years